Document is current
Any future updates will be listed below
-
Authors
Brossaud, Julie https://orcid.org/0000-0003-0831-9852
Bosch-Bouju, Clémentine https://orcid.org/0000-0001-8869-768X
Marissal-Arvy, Nathalie https://orcid.org/0000-0002-3147-5741
Campas-Lebecque, Marie-Neige
Helbling, Jean-Christophe https://orcid.org/0000-0001-7407-0114
Webster, Scott P. https://orcid.org/0000-0003-4656-4744
Walker, Brian R. https://orcid.org/0000-0002-2416-1648
Fioramonti, Xavier https://orcid.org/0000-0003-1713-4817
Ferreira, Guillaume https://orcid.org/0000-0001-5984-8143
Barat, Pascal https://orcid.org/0000-0001-5029-0200
Corcuff, Jean-Benoît https://orcid.org/0000-0003-3313-8447
Moisan, Marie-Pierre https://orcid.org/0000-0001-7315-5319
-
Funding
Funding for this research was provided by:
Société Française d'Endocrinologie et Diabétologie Pédiatrique (Prix de recherche SFEDP/SANDOZ 2018)
- License Information
-
More Information
Article History
Received: 12 January 2023
Accepted: 28 March 2023
First Online: 10 June 2023
Acknowledgements
: The development of UE2316 was funded by the Wellcome Trust.
: The data are available on request from the authors.
: This work was supported by a grant from SFEDP (Société Française d’Endocrinologie et Diabétologie Pédiatrique).
: BRW and SPW are inventors on relevant patents owned by the University of Edinburgh and licensed to Actinogen Medical Ltd. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: JB, CB-B, XF, PB, J-BC and M-PM contributed to the conception and design of the study. JB, J-CH, NM-A, M-NC-L, CB-B and M-PM acquired the data. JB, CB-B, SPW, BRW, XF, GF and M-PM analysed and interpreted the data. JB, CB-B, J-CH, XF and M-PM drafted the manuscript and JB, CB-B, NM-A, M-NC-L, SPW, BRW, GF, PB, J-BC and M-PM revised it. All authors approved the manuscript. JB and M-PM are the guarantors of this work.
Free to read: This content has been made available to all.
